HDC Labs Co Ltd
KRX:039570
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7 250
10 990
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
HDC Labs Co Ltd
Current Assets | 292B |
Cash & Short-Term Investments | 125.6B |
Receivables | 145.1B |
Other Current Assets | 21.3B |
Non-Current Assets | 72.8B |
Long-Term Investments | 25.6B |
PP&E | 15.1B |
Intangibles | 22.1B |
Other Non-Current Assets | 10B |
Current Liabilities | 96.1B |
Accounts Payable | 45.4B |
Other Current Liabilities | 50.7B |
Non-Current Liabilities | 14.8B |
Long-Term Debt | 4.1B |
Other Non-Current Liabilities | 10.7B |
Balance Sheet
HDC Labs Co Ltd
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
3 127
|
10 562
|
11 396
|
20 782
|
19 482
|
8 361
|
10 644
|
102 356
|
42 214
|
25 287
|
|
Cash |
6
|
2
|
2
|
5
|
3
|
1
|
1
|
113
|
2
|
7
|
|
Cash Equivalents |
3 121
|
10 560
|
11 394
|
20 777
|
19 479
|
8 360
|
10 643
|
102 243
|
42 212
|
25 280
|
|
Short-Term Investments |
11
|
62 075
|
62 036
|
54 205
|
69 217
|
65 413
|
118 312
|
89 741
|
70 542
|
113 155
|
|
Total Receivables |
39 886
|
50 491
|
64 116
|
83 610
|
59 225
|
57 845
|
56 775
|
116 342
|
158 787
|
144 212
|
|
Accounts Receivables |
39 878
|
50 471
|
64 085
|
83 593
|
59 192
|
57 805
|
54 993
|
112 727
|
133 946
|
140 050
|
|
Other Receivables |
8
|
20
|
31
|
17
|
33
|
40
|
1 782
|
3 615
|
24 841
|
4 162
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
9 892
|
6 857
|
8 388
|
9 360
|
9 179
|
|
Other Current Assets |
3 288
|
1 657
|
1 428
|
3 153
|
3 744
|
637
|
344
|
2 690
|
2 977
|
9 439
|
|
Total Current Assets |
46 312
|
124 785
|
138 977
|
161 750
|
151 668
|
142 148
|
192 932
|
319 516
|
283 880
|
301 271
|
|
PP&E Net |
5 066
|
4 876
|
4 627
|
4 576
|
5 100
|
5 623
|
5 230
|
26 605
|
20 042
|
16 845
|
|
PP&E Gross |
5 066
|
4 876
|
4 627
|
4 576
|
5 100
|
5 623
|
5 230
|
26 605
|
20 042
|
16 845
|
|
Accumulated Depreciation |
3 866
|
4 317
|
6 817
|
5 018
|
5 411
|
5 956
|
6 504
|
7 682
|
7 386
|
7 054
|
|
Intangible Assets |
766
|
484
|
351
|
373
|
466
|
889
|
1 046
|
13 646
|
13 884
|
14 448
|
|
Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9 264
|
9 264
|
9 264
|
|
Note Receivable |
101
|
66
|
29
|
0
|
0
|
5 129
|
6 091
|
5 964
|
4 867
|
3 246
|
|
Long-Term Investments |
79 858
|
87 435
|
94 194
|
106 367
|
128 126
|
69 975
|
5 455
|
22 105
|
26 656
|
25 213
|
|
Other Long-Term Assets |
409
|
685
|
1 858
|
2 843
|
4 681
|
13 455
|
7 243
|
14 291
|
23 987
|
13 045
|
|
Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9 264
|
9 264
|
9 264
|
|
Total Assets |
132 512
N/A
|
218 331
+65%
|
240 035
+10%
|
275 909
+15%
|
290 041
+5%
|
237 219
-18%
|
217 997
-8%
|
411 392
+89%
|
382 579
-7%
|
383 332
+0%
|
|
Liabilities | |||||||||||
Accounts Payable |
29 371
|
31 478
|
42 359
|
49 559
|
49 337
|
44 742
|
21 538
|
66 953
|
49 835
|
57 162
|
|
Accrued Liabilities |
2 030
|
3 452
|
4 190
|
5 878
|
5 519
|
3 891
|
5 859
|
23 778
|
22 646
|
21 385
|
|
Short-Term Debt |
19 500
|
3 000
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
144
|
529
|
400
|
4 237
|
3 458
|
3 406
|
|
Other Current Liabilities |
11 174
|
14 854
|
11 422
|
16 615
|
16 831
|
18 464
|
25 839
|
36 736
|
30 556
|
31 235
|
|
Total Current Liabilities |
62 075
|
52 784
|
57 970
|
72 052
|
71 832
|
67 626
|
53 636
|
131 703
|
106 496
|
113 187
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
602
|
617
|
437
|
11 083
|
8 730
|
5 844
|
|
Deferred Income Tax |
2 645
|
3 498
|
3 067
|
4 494
|
8 162
|
0
|
0
|
0
|
4
|
0
|
|
Minority Interest |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
4 313
|
2 544
|
3 172
|
2 612
|
1 820
|
350
|
14
|
2 798
|
6 832
|
5 780
|
|
Total Liabilities |
69 034
N/A
|
58 828
-15%
|
64 209
+9%
|
79 158
+23%
|
82 415
+4%
|
68 593
-17%
|
54 087
-21%
|
145 585
+169%
|
122 063
-16%
|
124 811
+2%
|
|
Equity | |||||||||||
Common Stock |
2 790
|
4 115
|
4 115
|
8 230
|
8 230
|
8 230
|
8 230
|
12 979
|
12 979
|
12 979
|
|
Retained Earnings |
64 599
|
78 008
|
94 421
|
116 021
|
126 357
|
114 854
|
85 474
|
87 653
|
91 139
|
89 554
|
|
Additional Paid In Capital |
1 776
|
83 476
|
83 476
|
79 319
|
79 319
|
79 319
|
80 147
|
183 196
|
183 196
|
183 196
|
|
Unrealized Security Profit/Loss |
5 693
|
6 061
|
285
|
492
|
7 911
|
34 417
|
170
|
93
|
1 203
|
792
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
10 098
|
18 113
|
28 003
|
28 003
|
|
Other Equity |
5
|
34
|
6 470
|
7 312
|
1 630
|
641
|
12
|
1
|
4
|
4
|
|
Total Equity |
63 478
N/A
|
159 503
+151%
|
175 826
+10%
|
196 751
+12%
|
207 626
+6%
|
168 627
-19%
|
163 910
-3%
|
265 807
+62%
|
260 517
-2%
|
258 521
-1%
|
|
Total Liabilities & Equity |
132 512
N/A
|
218 331
+65%
|
240 035
+10%
|
275 909
+15%
|
290 041
+5%
|
237 219
-18%
|
217 997
-8%
|
411 392
+89%
|
382 579
-7%
|
383 332
+0%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
11
|
16
|
16
|
16
|
16
|
16
|
15
|
24
|
23
|
23
|